Scholarlink

Background <p>Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. The <i>BRAF</i> V600E (c·1799T &gt; A; p.Val600Glu) mutation results in oncogenic activation of the MAP-kinase pathway and plays a key role in the development and aggressiveness of PTC. Significant morphological differences have been observed between BRAF V600E-mutated and non-mutated PTCs. The BRAF V600E mutation has been associated with adverse clinicopathological features, including lymph node metastasis, recurrence, tumor size, extrathyroidal invasion, and unfavorable outcomes, particularly when the mutant allele fraction is high. However, the relationship between the proportion of mutated neoplastic cells and the morphological characteristics of PTC remains unclear. This study aims to investigate the potential connection between the proportion of mutated neoplastic tumor cells and the morphological characteristics of PTC, and to evaluate the impact of normalizing the allele frequency to the percentage of neoplastic tumor cells in the tissue used for DNA extraction.</p> Methods <p>Eighty-five cases of PTC, spanning a 12-year period, were analysed with a focus on specific morphological features, including infiltrative tumor margin, plumps pink cells, desmoplasia and tumor size. Additional features included surgical margin status, lymph node and distant metastasis, multifocality, psammoma bodies, fibrosis, encapsulation and nuclear atypia. DNA mutation analysis was performed using pyrosequencing, and the percentage of neoplastic cells (MNC) was estimated from the slide used for DNA extraction. Normalization of the allele frequency was performed using a corresponding formula. Tumors were classified into three groups: subclonal ( &lt; 30% MNC), heterogeneous (30–80%) and clonal ( &gt; 80%). Statistical analysis, including interquartile range (IQR) calculations, was conducted.</p> Results <p>The frequency of mutated cases (BRAF V600E ≥10%) was 57 out of 85 cases (67%). The variables infiltrative tumor margins (<i>p</i> &lt; 0.001), plump pink cells (<i>p</i> = 0.007), and desmoplasia (<i>p</i> = 0.002) showed statistically significant associations with clonality, with the first remaining independently significant in the multivariate logistic regression analysis (<i>p</i> &lt; 0.001). Surgical margin status, distant metastasis, and tumor size also showed significance. Similar results were obtained using IQR analysis for the first three variables and for surgical margin status. The remaining variables did not reach statistical significance.</p> Conclusions <p>The presence of infiltrative tumor margin, plump pink cells, and myxoid desmoplasia, may serve as active markers associated with the normalized BRAF V600E mutation. These findings suggest that the mutation acts as a driver in both early and late stages of PTC development. Furthermore, a direct relationship between tumor size and clonality underscores the role of BRAF V600E mutation in tumor progression and morphological evolution.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Papillary thyroid carcinoma: morphological features and association with normalized BRAFV600E allelic frequency; clonality and morphology investigating mutations through microscopy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月2日

查看全文
  • Maria Soledad Martínez-Martin,
  • María Eugenia Galán-García,
  • Eduardo José Araujo-Ruano,
  • Eduardo Salido-Ruiz,
  • Mauro Boronat,
  • Pedro Saavedra-Santana,
  • Carlota Recio,
  • Juan José Cabrera-Galván

摘要

Background

Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. The BRAF V600E (c·1799T > A; p.Val600Glu) mutation results in oncogenic activation of the MAP-kinase pathway and plays a key role in the development and aggressiveness of PTC. Significant morphological differences have been observed between BRAF V600E-mutated and non-mutated PTCs. The BRAF V600E mutation has been associated with adverse clinicopathological features, including lymph node metastasis, recurrence, tumor size, extrathyroidal invasion, and unfavorable outcomes, particularly when the mutant allele fraction is high. However, the relationship between the proportion of mutated neoplastic cells and the morphological characteristics of PTC remains unclear. This study aims to investigate the potential connection between the proportion of mutated neoplastic tumor cells and the morphological characteristics of PTC, and to evaluate the impact of normalizing the allele frequency to the percentage of neoplastic tumor cells in the tissue used for DNA extraction.

Methods

Eighty-five cases of PTC, spanning a 12-year period, were analysed with a focus on specific morphological features, including infiltrative tumor margin, plumps pink cells, desmoplasia and tumor size. Additional features included surgical margin status, lymph node and distant metastasis, multifocality, psammoma bodies, fibrosis, encapsulation and nuclear atypia. DNA mutation analysis was performed using pyrosequencing, and the percentage of neoplastic cells (MNC) was estimated from the slide used for DNA extraction. Normalization of the allele frequency was performed using a corresponding formula. Tumors were classified into three groups: subclonal ( < 30% MNC), heterogeneous (30–80%) and clonal ( > 80%). Statistical analysis, including interquartile range (IQR) calculations, was conducted.

Results

The frequency of mutated cases (BRAF V600E ≥10%) was 57 out of 85 cases (67%). The variables infiltrative tumor margins (p < 0.001), plump pink cells (p = 0.007), and desmoplasia (p = 0.002) showed statistically significant associations with clonality, with the first remaining independently significant in the multivariate logistic regression analysis (p < 0.001). Surgical margin status, distant metastasis, and tumor size also showed significance. Similar results were obtained using IQR analysis for the first three variables and for surgical margin status. The remaining variables did not reach statistical significance.

Conclusions

The presence of infiltrative tumor margin, plump pink cells, and myxoid desmoplasia, may serve as active markers associated with the normalized BRAF V600E mutation. These findings suggest that the mutation acts as a driver in both early and late stages of PTC development. Furthermore, a direct relationship between tumor size and clonality underscores the role of BRAF V600E mutation in tumor progression and morphological evolution.